Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Medigus Ltd ADR (MDGS)

Medigus Ltd ADR (MDGS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,702
  • Shares Outstanding, K 15,822
  • Annual Sales, $ 10,120 K
  • Annual Income, $ 6,790 K
  • 60-Month Beta N/A
  • Price/Sales 0.92
  • Price/Cash Flow 2.13
  • Price/Book 0.17
Trade MDGS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/01/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4279 +28.53%
on 09/27/22
0.7490 -26.57%
on 09/23/22
-0.0999 (-15.37%)
since 08/30/22
3-Month
0.4279 +28.53%
on 09/27/22
0.7490 -26.57%
on 09/23/22
-0.0950 (-14.73%)
since 06/30/22
52-Week
0.4279 +28.53%
on 09/27/22
1.7800 -69.10%
on 10/28/21
-1.0300 (-65.19%)
since 09/30/21

Most Recent Stories

More News
Medigus: ParaZero Signed a Non - Binding MOU to Provide Autonomous Safety Systems for Bon V Heavy Lift Cargo Drones

Tel Aviv, Israel, July 05, 2022 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative...

MDGS : 0.5500 (-6.45%)
Medigus: Eventer Signs Agreements with Two Teams from the Israeli Basketball Premier League and the Israeli National Basketball League

Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe Tel Aviv, Israel,...

MDGS : 0.5500 (-6.45%)
Medigus: ScoutCam Signs a Joint Development Agreement to Equip Aerial Platforms of a Top Global Defense and Aviation Manufacturer with In-Flight Monitoring Solutions

Tel Aviv, Israel, June 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions,...

MDGS : 0.5500 (-6.45%)
SCTC : 5.9900 (+8.91%)
Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Tel Aviv, Israel, June 17, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions,...

MDGS : 0.5500 (-6.45%)
Medigus: ScoutCam Completes Verification & Validation for Miniature Camera Solution with Fortune 500 Customer

Tel Aviv, Israel, June 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions,...

MDGS : 0.5500 (-6.45%)
SCTC : 5.9900 (+8.91%)
Medigus Announces Record Fiscal Year 2021 Financial Results

Record Revenues of $10.1 million, up 1,805% over 202047% gross margin and 40% net margin$4 million net income for the full year, up from a net loss of $6.9...

MDGS : 0.5500 (-6.45%)
Medigus to Invest in a Deep Energy Tech Company

New investment targets improving and optimizing the global water, oil, and gas transportation infrastructure through cutting-edge technology that reduces...

MDGS : 0.5500 (-6.45%)
Medigus: Polyrizon’s PL-15 Found Effective Against Highly Transmissible SARS-CoV-2 Omicron Variant in Cell Culture Assays

The results are consistent with a series of Polyrizon's previous successful tests in human coronavirus 229E and Influenza Virus H1N1 ...

MDGS : 0.5500 (-6.45%)
Medigus Announces Final Airworthiness Criteria Published by the FAA

Leading drone company using ParaZero's SafeAir™ system is heading towards completing final regulatory process of type certification with the U.S. Federal...

MDGS : 0.5500 (-6.45%)
Medigus: Gix Internet Reports Over $45 Million in Revenues for 2021

Medigus expects to consolidate Gix Internet’s financial results during 2022 Tel Aviv, Israel, March 31, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq:...

MDGS : 0.5500 (-6.45%)
GIX : 9.38 (-10.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medigus Ltd. is a technology company engaged in advanced medical solutions, internet technologies and electric vehicle and charging solutions. Medigus Ltd. is based in Tel Aviv, Israel.

See More

Key Turning Points

3rd Resistance Point 0.7231
2nd Resistance Point 0.6725
1st Resistance Point 0.6113
Last Price 0.5500
1st Support Level 0.4995
2nd Support Level 0.4489
3rd Support Level 0.3877

See More

52-Week High 1.7800
Fibonacci 61.8% 1.2635
Fibonacci 50% 1.1040
Fibonacci 38.2% 0.9444
Last Price 0.5500
52-Week Low 0.4279

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar